Similar articles

• [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].

  González-Manzano R. González-Manzano R. Med Clin (Barc). 1994 Apr 9;102(13):506-15. Med Clin (Barc). 1994. PMID: 7911549 Review. Spanish. No abstract available.
• [Glycoprotein in multidrug-resistant malignancies--clinical implications].

  Ellis A, Lishner M, Manor J, Ravid M. Ellis A, et al. Harefuah. 1994 Mar 15;126(6):334-7. Harefuah. 1994. PMID: 7910806 Review. Hebrew. No abstract available.
• [Perspectives on modulation of chemoresistance of malignant diseases].

  Allerödder HP, Ukena D, Sybrecht GW. Allerödder HP, et al. Pneumologie. 1993 Sep;47(9):513-7. Pneumologie. 1993. PMID: 7901849 Review. German. No abstract available.
• The multidrug resistance phenotype in human cancer.

  Cordon-Cardo C, O'Brien JP. Cordon-Cardo C, et al. Important Adv Oncol. 1991:19-38. Important Adv Oncol. 1991. PMID: 1678363 Review. No abstract available.
• Resistance to natural products in leukemia.

  Borst P, Baas F, Lincke CR, Schinkel AH, Smit JJ, Van der Velde-Koerts T. Borst P, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:44-7. Bone Marrow Transplant. 1990. PMID: 1975205 Review. No abstract available.